Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
DVAX [NASD]
Dynavax Technologies Corporation
Index- P/E- EPS (ttm)-0.32 Insider Own3.32% Shs Outstand262.91M Perf Week2.08%
Market Cap386.48M Forward P/E- EPS next Y-0.34 Insider Trans0.29% Shs Float261.06M Perf Month4.26%
Income-75.80M PEG- EPS next Q-0.09 Inst Own67.20% Short Float10.10% Perf Quarter4.26%
Sales12.30M P/S31.42 EPS this Y7.30% Inst Trans0.00% Short Ratio17.94 Perf Half Y-5.77%
Book/sh0.57 P/B2.58 EPS next Y0.00% ROA-45.80% Target Price4.50 Perf Year23.53%
Cash/sh0.59 P/C2.50 EPS next 5Y- ROE-52.00% 52W Range1.10 - 2.14 Perf YTD-25.00%
Dividend- P/FCF- EPS past 5Y6.10% ROI-35.60% 52W High-31.31% Beta2.37
Dividend %- Quick Ratio8.00 Sales past 5Y-21.20% Gross Margin- 52W Low33.64% ATR0.07
Employees151 Current Ratio8.00 Sales Q/Q-11.80% Oper. Margin- RSI (14)53.75 Volatility4.55% 4.76%
OptionableYes Debt/Eq0.00 EPS Q/Q0.00% Profit Margin- Rel Volume1.72 Prev Close1.51
ShortableYes LT Debt/Eq0.00 EarningsNov 05 BMO Payout- Avg Volume1.47M Price1.47
Recom1.80 SMA201.91% SMA503.19% SMA200-7.01% Volume2,505,300 Change-2.65%
25-Nov-13Upgrade MLV & Co Hold → Buy $1.50 → $5
25-Feb-13Downgrade MLV & Co Buy → Hold
16-Nov-12Reiterated MLV & Co Buy $10 → $7.50
04-Jan-12Initiated MLV & Co Buy $8
09-Nov-10Reiterated Wedbush Outperform $6 → $8
08-Nov-10Initiated Jefferies Buy $4
13-May-10Upgrade Wedbush Neutral → Outperform $2.60 → $6
20-Mar-09Initiated Wedbush Morgan Buy $1.20
22-Oct-08Downgrade Oppenheimer Outperform → Perform
19-May-08Reiterated Susquehanna Financial Positive $7 → $5
19-May-08Downgrade Bear Stearns Outperform → Peer Perform
18-Mar-08Downgrade Merriman Curhan Ford Buy → Neutral
22-Feb-08Upgrade Oppenheimer Perform → Outperform $8.50
03-Oct-07Initiated Credit Suisse Outperform $8
06-Jun-07Initiated Susquehanna Financial Positive
26-Feb-07Downgrade JMP Securities Mkt Outperform → Mkt Perform
14-Oct-14 04:12PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online +5.07%
03:45PM  Dynavax Initiates Phase I/II Trial on Lymphoma Candidate Zacks
13-Oct-14 06:00AM  Dynavax Initiates Phase 1/2 Study of TLR-9 Agonist Immunotherapy in B-Cell Lymphoma Marketwired
07-Oct-14 04:04PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
04:00PM  Dynavax Announces Resignation of Dino Dina From Board of Directors Marketwired
23-Sep-14 04:00PM  Dynavax (DVAX) Completes Enrolment for Study on Heplisav Zacks
22-Sep-14 04:15PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
07:49AM  Dynavax (DVAX) Jumps: Stock Moves 6.7% Higher Zacks
06:00AM  Dynavax Completes Enrollment of Phase 3 Study of HEPLISAV-B(TM) Marketwired
15-Aug-14 01:04PM  DYNAVAX TECHNOLOGIES CORP Financials EDGAR Online Financials
08-Aug-14 04:10PM  Dynavax Technologies Q2 Loss Wider than Expected, Sales Beat Zacks
07-Aug-14 04:30PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online -5.26%
04:17PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
06:00AM  Dynavax Reports Second Quarter 2014 Financial Results and Safety and Pharmacodynamic Results for Asthma and Lupus Drug Candidates Marketwired
30-Jul-14 08:01AM  Dynavax Technologies (DVAX) Jumps: Stock Gains 6.4% Zacks
04-Jul-14 07:52AM  Better Buy: Dynavax Technologies Corp. vs. Geron Corp. at Motley Fool
18-Jun-14 08:35AM  Will Dynavax (DVAX) Continue to Surge Higher? Zacks
09-Jun-14 04:00PM  Dynavax to Present at the William Blair 2014 Growth Stock Conference Marketwired
06-Jun-14 01:15PM  2 Small-Cap Biotechs for Your Watchlist at Motley Fool
02-Jun-14 04:00PM  Dynavax to Present at the Jefferies Global Healthcare Conference Marketwired
29-May-14 04:16PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a V EDGAR Online
27-May-14 08:35AM  Dynavax (DVAX) Sees Hammer Chart Pattern: Time to Buy? Zacks
08-May-14 06:32PM  Why Dynavax Technologies Corporation Should Be on Your Watchlist at Motley Fool -12.16%
06-May-14 10:50AM  Dynavax Reports In Line Q1 Results Zacks -7.01%
05-May-14 04:46PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online
04:31PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
09:00AM  Dynavax Reports First Quarter 2014 Financial Results Marketwired
30-Apr-14 06:00PM  Five Small Biotech Stocks Analysts Think Will Triple at Forbes
24-Apr-14 07:06AM  Ambit Biosciences Slumps: AMBI Falls 7.1% in Session Zacks
17-Apr-14 06:51AM  What Falling Estimates & Price Mean for Discovery Laboratories (DSCO) Zacks
16-Apr-14 04:30PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
03:10PM  Dynavax Starts Phase III Study on Heplisav-B Zacks
15-Apr-14 09:44AM  Tuesdays Top Health Care Stories: Johnson & Johnson, Teva, Mylan, and Dynavax at Motley Fool
06:00AM  Dynavax Initiates Phase 3 Study of HEPLISAV-B(TM) Marketwired
21-Mar-14 06:31PM  Does Mannkind Offer a Good Risk to Reward Ratio? at Motley Fool
13-Mar-14 11:00AM  4 Health Care Stocks With More Than 100% Upside StreetAuthority Network
11-Mar-14 08:10AM  Wider Q4 Loss at Dynavax Zacks
10-Mar-14 04:37PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online
04:14PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 10-K, Annual Report EDGAR Online
04:00PM  Dynavax Reports Fourth Quarter and Year End 2013 Financial Results Marketwired
07-Mar-14 05:45PM  Scandal-Ridden SAC Capital Buys Broadcom, Dynavax, and Boston Scientific at Motley Fool
06-Mar-14 08:20AM  Will Dynavax (DVAX) Continue to Surge Higher? Zacks -5.39%
05-Mar-14 02:59PM  Dynavax: An Update On This Speculative $2 Biotech Play at Seeking Alpha
10:40AM  Dynavax Receives Milestone Payments from AstraZeneca Zacks
04-Mar-14 04:45PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online +5.29%
03-Mar-14 04:00PM  Dynavax to Receive $5.4 Million Milestone Marketwired
28-Feb-14 04:00PM  Dynavax to Present at the 34th Annual Cowen & Company Health Care Conference Marketwired
20-Feb-14 05:20PM  Dynavax Withdraws MAA on Heplisav Zacks
18-Feb-14 04:47PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
02:31PM  3 Biotech Stocks with Great Upside: Inovio Pharmaceuticals, Dynavax, and Ariad at Motley Fool
10:00AM  Dynavax withdraws EU marketing application for Hep B vaccine Reuters
09:00AM  Dynavax Announces Withdrawal of European Marketing Application for HEPLISAV(TM) Marketwired
12-Feb-14 03:45PM  Tekmira Announces New Appointment to Board of Directors GlobeNewswire
07-Feb-14 04:52PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
21-Jan-14 01:53PM  A Glimpse At Our Small Cap Biotechnology Portfolio at Seeking Alpha -5.31%
19-Jan-14 09:19AM  3 Good Speculative Stocks For Under $3 A Share at Seeking Alpha
10-Jan-14 05:00PM  Dynavax to Present at the 32nd Annual J.P. Morgan Healthcare Conference Marketwired
04:10PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
07:05AM  Buyout Picks In Healthcare For 2014 at Seeking Alpha
06-Jan-14 08:04AM  Positioning For 2014 In The Health Care Sector at Seeking Alpha
30-Dec-13 11:18AM  The 5 Most Common Infectious Diseases at Motley Fool
07:19AM  2 Speculative, But Attractive $2 Biotech Plays at Seeking Alpha
26-Dec-13 10:26AM  Will Dynavax Technologies Corporation Bounce Back in 2014? at Motley Fool
24-Dec-13 11:10AM  Dynavax Submits Response to EMA Zacks
08:28AM  Make Or Break Catalysts Approaching For Dynavax at Seeking Alpha
19-Dec-13 04:02PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
09:00AM  Dynavax Announces Submission of Responses to EMA Day 120 List of Questions for HEPLISAV(TM) MAA Marketwired
03:33AM  Dynavax: Embarking On A Run Propelled By 2 Potential Approvals at Seeking Alpha
10-Dec-13 02:28AM  Dynavax, MannKind, and Orexigen Could Have a Big Year in 2014 at Motley Fool
27-Nov-13 05:11PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exh EDGAR Online
04:45PM  Dynavax Announces Resignation of J. Tyler Martin From Board of Directors Marketwired
25-Nov-13 08:06AM  Dynavax Technologies upgraded by MLV & Co Briefing.com +6.21%
Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops products to prevent and treat infectious and inflammatory diseases, and cancer. It develops product candidates based on the use of immunostimulatory sequences and immunoregulatory sequences. Its lead product candidate is HEPLISAV, a investigational adult hepatitis B vaccine which is in Phase III clinical trials. The company also develops DV1179, a TLR inhibitor of TLR 7 and TLR9 for the treatment of autoimmune and inflammatory diseases that is in Phase I clinical trials; AZD1419, a candidate drug for the treatment of asthma, which is in Phase I clinical trials; SD-101, a second-generation TLR 9 agonist for immunotherapy of cancer that is in Phase I clinical trials; and DV230, an adjuvant platform that is in preclinical studies. It has a strategic alliance with GlaxoSmithKline to discover, develop, and commercialize TLR inhibitors; and a research collaboration and license agreement with AstraZeneca AB for the discovery and development of TLR9 agonist-based therapies for the treatment of asthma and chronic obstructive pulmonary disease. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was founded in 1996 and is based in Berkeley, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gray EddieCEO and DirectorAug 14Buy1.4925,00037,25025,000Aug 14 04:18 PM
KISNER DANIEL LDirectorOct 30Buy1.0810,00010,75015,000Oct 30 04:30 PM
Phillips Peggy VDirectorOct 30Buy1.0893,023100,000138,023Oct 30 04:29 PM
ORONSKY ARNOLD LDirectorOct 30Buy1.08186,047200,001375,055Oct 30 04:29 PM